A000227 logo

Yuyu Pharma KOSE:A000227 Stock Report

Last Price

₩9.59k

Market Cap

₩73.8b

7D

-1.0%

1Y

-20.8%

Updated

24 Dec, 2024

Data

Company Financials

My Notes

Capture your thoughts, links and company narrative

Yuyu Pharma, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Yuyu Pharma
Historical stock prices
Current Share Price₩9,590.00
52 Week High₩15,970.00
52 Week Low₩9,030.00
Beta0.51
1 Month Change-5.52%
3 Month Change-9.36%
1 Year Change-20.81%
3 Year Change-49.53%
5 Year Change2.02%
Change since IPO324.34%

Recent News & Updates

Recent updates

Shareholder Returns

A000227KR PharmaceuticalsKR Market
7D-1.0%1.8%-2.1%
1Y-20.8%4.3%-9.0%

Return vs Industry: A000227 underperformed the KR Pharmaceuticals industry which returned 4.3% over the past year.

Return vs Market: A000227 underperformed the KR Market which returned -9% over the past year.

Price Volatility

Is A000227's price volatile compared to industry and market?
A000227 volatility
A000227 Average Weekly Movement10.0%
Pharmaceuticals Industry Average Movement5.6%
Market Average Movement6.6%
10% most volatile stocks in KR Market12.7%
10% least volatile stocks in KR Market3.3%

Stable Share Price: A000227's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A000227's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
1941253Robert Yuwww.yuyu.co.kr

Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea.

Yuyu Pharma, Inc. Fundamentals Summary

How do Yuyu Pharma's earnings and revenue compare to its market cap?
A000227 fundamental statistics
Market cap₩73.79b
Earnings (TTM)₩8.56b
Revenue (TTM)₩134.79b

8.6x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A000227 income statement (TTM)
Revenue₩134.79b
Cost of Revenue₩83.69b
Gross Profit₩51.10b
Other Expenses₩42.55b
Earnings₩8.56b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)528.76
Gross Margin37.91%
Net Profit Margin6.35%
Debt/Equity Ratio26.4%

How did A000227 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 02:46
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yuyu Pharma, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hyung Soo KimCape Investment & Securities Co., Ltd.